Stockscreener 앱 받기
3.77
0.79%
-0.03
시간 외 거래:
3.80
0.03
+0.80%
Onconetix Inc 주식(ONCO)의 최신 뉴스
Onconetix Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com
What drives Onconetix Inc. stock priceSuperior profit margins - jammulinksnews.com
What makes Onconetix Inc. stock price move sharplyDaily Gain Forecast - Newser
What analysts say about Onconetix Inc. stockPhenomenal wealth increase - printweek.in
Is Onconetix Inc. a good long term investmentSuperior returns - PrintWeekIndia
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders - The Malaysian Reserve
Halper Sadeh investigates Onconetix, Waters, and Longevity Health Holdings mergers. - AInvest
Can Onconetix Inc. stock recover from recent declineFree Insider Trading Tips - Newser
Onconetix Announces Merger with Ocuvex Therapeutics - The Globe and Mail
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Onconetix Shares Plunge 22.52% Amid Dilutive Merger - AInvest
Onconetix, Ocuvex execute definitive merger agreement - TipRanks
ONCO Stock on the Rise: A Promising Investment - investchronicle.com
Onconetix Shares Collapse 19% as Merger Uncertainties Collide with Legal Risks - AInvest
Onconetix Merger: Navigating Legal Risks and Market Volatility - AInvest
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders - The Globe and Mail
Onconetix Crashes 18% as Merger with Ocuvex Sparks Dilution Fears and Liquidity Concerns - AInvest
Onconetix to buy privately held Ocuvex Therapeutics (ONCO) - Seeking Alpha
Onconetix To Merge With Ocuvex Therapeutics - Nasdaq
Onconetix Soars 13.69% on Ocuvex Merger Announcement - AInvest
Onconetix and Ocuvex Therapeutics announce definitive merger agreement By Investing.com - Investing.com Nigeria
Onconetix and Ocuvex Therapeutics announce definitive merger agreement - Investing.com Australia
Onconetix, Inc. and Ocuvex Therapeutics, Inc. Announce Definitive Merger Agreement - Nasdaq
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewswire
Major Biotech Merger: Ocuvex Takes 90% Control of Onconetix to Advance Ophthalmic Pipeline - Stock Titan
How Onconetix Inc. stock performs during market volatilitySafety First Trading Signals - Newser
Why Onconetix Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser
Onconetix Secures Nasdaq Listing with Panel Decision - TipRanks
Onconetix receives positive decision by Nasdaq Hearings Panel - TipRanks
Onconetix regains Nasdaq compliance after filing Q1 report - Investing.com
Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel - MarketScreener
0.51%
자본화:
|
볼륨(24시간):